Aleafia to Release Q3 Results on Nov 26, Hold First Ever Results Call
TORONTO, November 12, 2018 /Globe Newswire/ – Aleafia Health Inc. (TSXV: ALEF; OTCQX: ALEAF, FRA: ARAH) (“Aleafia“) or (the “Company“), a highly differentiated cannabis company with major cannabis cultivation and medical clinic operations, will release its financial results and hold its Third Quarter Results Call on November 26, 2018.
Read Press Release
Letter from Chairman Julian Fantino
There are few industries that evolve as rapidly as the cannabis industry. That has certainly been the case for Aleafia. In that vein, I am pleased to provide our shareholders with an update on some key initiatives being pursued by the company.
Read Press Release
Aleafia Announces Special Meeting of Shareholders
TORONTO, November 7, 2018 /Globe Newswire/ – Aleafia Health Inc. (TSXV: ALEF; OTCQX: ALEAF, FRA: ARAH) (“Aleafia“) or (the “Company“) is announcing that it will hold a special meeting (the “Meeting”) of shareholders on Thursday, December 6, 2018 at 9:00 a.m. (Toronto time) at Famee Furlane Club – Friuli Hall, 7065 Islington Avenue, Woodbridge, ON. […]
Read Press Release
Aleafia Launches Global Expansion with Proposed Equity Stake in Australian Licensed Cannabis Company
Aleafia to Distribute Medical Cannabis, Provide Technical Expertise to CannaPacific
Read Press Release
Aleafia Labs Partners on Cannabinoid Pharmacogenetics Study
Study with G420, US-Based AKESOgen aimed at producing genetic tools for improved medical cannabis therapy
Read Press Release
Aleafia to Launch Cannabis R&D Division Aleafia Labs
Patient Data, Intellectual Property to be Used in Development of Proprietary Products
Read Press Release
Aleafia, Serruya Family Extend Exclusivity Period for Retail and Brand Joint-Venture
Major Adult-Use Retail, Brand JV Backed by Family Behind Iconic Yogen Früz, Second Cup Brands
Read Press Release
Aleafia Launches Three New Clinics, Telemedicine Treatment in Significant Expansion
Six Physicians, Nurse Practitioners Also Joining Canabo Medical Clinics
Read Press Release
Aleafia to Launch Industry First 60,000 kg Secure Outdoor Grow Expansion
Low Cost Expansion to Increase Aleafia’s Annual Production Capacity to 98,000 kg
Read Press Release
Aleafia Submits Application to List on NASDAQ
Up-Listing to NASDAQ to Provide Greater Exposure to U.S. Investors
Read Press Release
Aleafia Signs Cannabis Supply MOU with CannTrust for up to 15,000 kg in 2019
Clinic Operations and Previous Cannabis Sales Providing Immediate, Significant Revenue to Aleafia
Read Press Release
Aleafia Announces Launch of Early Warrant Incentive Program
Gross Proceeds of Program to Reach up to $21.1M
Read Press Release
Aleafia Added to Leading Cannabis ETF After Surge in Business Performance
Horizons Marijuana Life Sciences ETF has $1.1B Invested in Cannabis Sector
Read Press Release
Aleafia Partners With Cronos Group on Medical Cannabis Sleep Study
TORONTO, September 20, 2018 /Globe Newswire/ – Aleafia Health Inc. (TSXV: ALEF; OTCQX: ALEAF, FRA: ARAH) (“Aleafia“) and Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group”) are pleased to announce the commencement of a joint medical cannabis study to improve the management and treatment of insomnia and daytime sleepiness.
Read Press Release
VIDEO: Aleafia’s 160,000 sq. ft. Greenhouse Retrofitting on Schedule
Video Provides Inside Look at Aleafia’s two Fully Funded, Modern Production Facilities
Read Press Releasex
By subscribing, I accept the Terms of Service & Privacy Policy, and I understand I can unsubscribe at any time.